Key Sessions
Nicole Borth
KEYNOTE: How to Train Your Cell
BOKU University and Austrian Center of Industrial Biotechnology
Christoph Herwig, PhD
Lifecycling of Hybrid Digital Twins: Strategies to Generate, Adapt and Deploy Digital Twins
Vienna University of Technology, Austria & Senior Scientific Advisor, Körber AG, Austria
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
May 17 - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
May 17 - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
07:30 - 08:2050 mins
General Session
Coffee and Registration
08:20 - 08:3010 mins
Cell Line Development and Engineering - Strauss 2 and 3
Chairperson’s Opening Remarks
- Raja Srinivas - Founder, Asimov
08:20 - 08:3010 mins
Cell Culture - Strauss 1
Chairperson’s Opening Remarks
- Mark Duerkop - Chief Executive Officer, Novasign
08:20 - 08:3010 mins
Recovery & Purification - Lehar 1 and 2
Chairperson's Opening Remarks
- Ger Brophy - Executive Vice President, Biopharma Production, Avantor, USA
08:20 - 08:3010 mins
Viral Safety - Lehar 3
Chairperson’s Opening Remarks
- David Gemmell - Biomanufacturing Engineer, Merck
08:20 - 08:3010 mins
Cell & Gene Therapy - Lehar 4
Chairperson’s Opening Remarks
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
08:30 - 09:0030 mins
Cell Line Development and Engineering - Strauss 2 and 3
KEYNOTE: Cell Engineering Using Synthetic Biology
- Kerstin Otte, PhD - Professor, University of Applied Sciences Biberach
08:30 - 09:0030 mins
Cell Culture - Strauss 1
PAT for vaccine manufacturing: integrated upstream and downstream applications
- Sarah Touw-Mercier, Remote - Senior Scientist, USP, Janssen, Pharmaceutical Companies of Johnson and Johnson
08:30 - 09:0030 mins
Recovery & Purification - Lehar 1 and 2
Lifecycling of Hybrid Digital Twins: Strategies to Generate, Adapt and Deploy Digital Twins
- Christoph Herwig, PhD - Full Professor for Biochemical Engineering, Vienna University of Technology, Austria & Senior Scientific Advisor, Körber AG, Austria
08:30 - 09:0030 mins
Viral Safety - Lehar 3
Strategies for Upstream Viral Risk Mitigation
- David Gemmell - Biomanufacturing Engineer, Merck
08:30 - 09:0030 mins
Cell & Gene Therapy - Lehar 4
CGT Process Development - Challenges and Avenues
- Hemant Dhamne, Remote - Head, Process Development, Gene Therapy Vector Facility, King's College London, UK
09:00 - 09:3030 mins
Cell Line Development and Engineering - Strauss 2 and 3
KEYNOTE: Transcriptional reprogramming of CHO cells
- Alan Dickson, Ph.D. - Professor, University of Manchester
09:00 - 09:3030 mins
Cell Culture - Strauss 1
The road to digitalisation of a research lab
- Steffie Eggermont - Senior Scientist, UCB
09:00 - 09:3030 mins
Recovery & Purification - Lehar 1 and 2
Integrated process modelling and machine-learning in downstream process development
- Cécile Brocard, PhD - Director, Downstream Development, Biopharma Process Science Austria, Boehringer Ingelheim RCV GmbH & Co KG
09:00 - 09:3030 mins
Viral Safety - Lehar 3
Advancing Bioprocess Operations From Pressure to Pump: Robustness Of Pump Based Virus Filtration, Including Pressure Ramp-Up Phase
- Mathithas Kandasamy - Senior Product Manager, Asahi Kasei Bioprocess Europe
09:00 - 09:3030 mins
Cell & Gene Therapy - Lehar 4
Development of Viral Vectors for Gene Therapy
- Catarina Vieira - Principal Scientist, Oxford Biomedica
09:30 - 10:0030 mins
Cell Line Development and Engineering - Strauss 2 and 3
The Leap-In Transposase Platform: Past, Present and Future
- Oren Beske, Ph.D. - Amalgamator of Business and Biology, ATUM
09:30 - 10:0030 mins
Cell Culture - Strauss 1
Power up your process control with rapid at line MS-based key nutrient monitoring
- Graziella Piras Ph.D, - Bioprocessing Segment Marketing Director, 908 Devices
09:30 - 10:0030 mins
Recovery & Purification - Lehar 1 and 2
Thermo Scientific DynaChrom Single-Use Chromatography System
- Floris Hooijenga, MBA - Global Commercial Sales Leader, BioProcessing Equipment & Automation, Thermo Fisher
09:30 - 10:0030 mins
Viral Safety - Lehar 3
Biological Validation of Column-based Continuous Viral Inactivation
- Moo Sun Hong - Postdoctoral Associate, MIT
09:30 - 10:0030 mins
Cell & Gene Therapy - Lehar 4
Use of a Novel Cell Lysis Buffer for Protection of AAVs and Enhancing Manufacturing Efficiency
- Nandu Deorkar, PhD - Vice President, Research & Development, Avantor
10:00 - 10:3030 mins
General Session
Diversity, Equity & Inclusion Coffee Morning
- Hemant Dhamne, Remote - Head, Process Development, Gene Therapy Vector Facility, King's College London, UK
10:30 - 11:0030 mins
Cell Line Development and Engineering - Strauss 2 and 3
KEYNOTE: Modifying RNA epigenetics to improve the production of recombinant products
- Niall Barron - Principal Investigator, NIBRT
10:30 - 11:0030 mins
Cell Culture - Strauss 1
Development and Qualification of a Representative Small-Scale Model for recombinant protein manufacturing in Perfusion
- Barak Hajaj - Head of USP Development, Ferring
10:30 - 11:0030 mins
Recovery & Purification - Lehar 1 and 2
Evaluating Liposome Sterile Filtration Through Applying Complementary 3D Imaging Techniques
- Dan Bracewell, Ph.D., Remote - Professor, Chemical Engineering, University College London
10:30 - 11:0030 mins
Viral Safety - Lehar 3
Pathogen Safety by Design
- Tobias Schraeder - Manager, Virus Validation, Global Pathogen Safety (GPS), CSL Behring Innovation GmbH
10:30 - 11:0030 mins
Cell & Gene Therapy - Lehar 4
Design of a Central Workflow Platform for AAV-Manufacturing Process Development
- Jana Hersch - Scientific Consultant, Genedata
11:00 - 11:3030 mins
Cell Line Development and Engineering - Strauss 2 and 3
KEYNOTE: How to Train Your Cell
- Nicole Borth - Professor, BOKU University and Austrian Center of Industrial Biotechnology
11:00 - 12:0060 mins
Cell Culture - Strauss 1
Collaborative Innovation Addresses New CHO Manufacturing Needs from Media to Clarification
- Geoffroy Malherbe - EMEA Single-Use Technologies Sr Sales Manager, Thermo Fisher Scientific
- Hani El-Sabbahy - Bioprocess Applications Specialist, 3M
11:00 - 11:3030 mins
Recovery & Purification - Lehar 1 and 2
Monitoring Protein Aggregate Content During Bind-and-Elute Chromatographic Purification: Towards A Proof of Concept
- Daniel Some - Principal Scientist, Wyatt Technology Corp, USA, (A Representative of Biophorum Working Group)
11:00 - 11:3030 mins
Viral Safety - Lehar 3
Production Sterility for Batch and Continuous Virus Filtration Processes
- Nigel Jackson, Remote - Principal Engineer, Pall
11:00 - 11:3030 mins
Cell & Gene Therapy - Lehar 4
Developing a Control Strategy for Full to Empty AAV Particles
- Franz Schnetzinger, Remote - VP QC and CMC Analytical Development, Gyroscope Therapeutics
11:30 - 12:0030 mins
Cell Line Development and Engineering - Strauss 2 and 3
CHO Media Panel Assessment: A Case Study
- Noemi Moroni - Process Development Upstream Team Leader, Menarini Biotech, Italy
11:30 - 12:0030 mins
Recovery & Purification - Lehar 1 and 2
Increased Viral Clearance in Downstream Process Manufacturing Through Use of Novel Purification Resins and Additives
- Nandu Deorkar, PhD - Vice President, Research & Development, Avantor
11:30 - 12:0030 mins
Viral Safety - Lehar 3
Accelerating Viral Clearance Studies: A Multi-Virus Approach
- Anja Tessarz, PhD - Scientific Specialist, Viral Clearance, Biologics Testing Solutions, Charles River Laboratories
11:30 - 12:0030 mins
Cell & Gene Therapy - Lehar 4
Purify small drug volumes better – GMP manufacturing of viral vectors
- Sushma Nayak Teichert - Global Product Manager, Cytiva
12:00 - 13:1070 mins
Sponsored Luncheon Presentation 1
Multi-Column Chromatography for Early-Stage Process Development
- David Johnson - Team Lead Chromatography Systems Product Management, Sartorius
12:00 - 13:1070 mins
Sponsored Luncheon Presentation 2
Sponsored Luncheon Presentation by Cytiva: Chromatography modeling trends: Digital twins and more
- Nick Whitelock, EngD - Commercial Modelling Specialist, GoSilico, Cytiva
12:00 - 13:1070 mins
Sponsored Luncheon Presentation 3
ChromNeX: a stackable, bed-supported chromatography device enabling intensified downstream processing
- Guido Ströhlein, PhD, MBA - Vice President Life Sciences, JSR Micro NV
13:10 - 13:155 mins
Cell Line Development and Engineering - Strauss 2 and 3
Chairperson's Remarks
13:10 - 13:155 mins
Cell Culture - Strauss 1
Chairperson's Remarks
- Mark Duerkop - Chief Executive Officer, Novasign
13:10 - 13:155 mins
Recovery & Purification - Lehar 1 and 2
Chairperson's Remarks
- Ger Brophy - Executive Vice President, Biopharma Production, Avantor, USA
13:10 - 13:155 mins
Viral Safety - Lehar 3
Chairperson's Remarks
- David Gemmell - Biomanufacturing Engineer, Merck
13:15 - 13:4530 mins
Cell Line Development and Engineering - Strauss 2 and 3
Going beyond the limit: tuning global transcription and translation activity increases recombinant protein secretion in Pichia pastoris
- Brigitte Gasser - Professor, BOKU
13:15 - 13:4530 mins
Cell Culture - Strauss 1
Raman-based monitoring of amino acids and antibody N-glycosylation in high cell density perfusion culture
- Hubert Schwarz - PhD Student, Cell Technology Group, KTH Royal Institute of Technology
13:15 - 13:4530 mins
Recovery & Purification - Lehar 1 and 2
Development Approach of an Intensified Integrated Continuous Process for Pilot Scale
- Veronique Chotteau, PhD - Associate Professor, Principal Investigator of the Cell Technology group, Dept. Industrial Biotechnology, School of Engineering Sciences in Chemistry, Biotechnology, and Health, KTH (Royal Institute of Technology)
13:15 - 13:4530 mins
Viral Safety - Lehar 3
Considerations for Implementation of Continuous Inline Virus Inactivation
- Cindy Delagree - Global Product Manager, Merck Group
13:40 - 13:455 mins
Cell & Gene Therapy - Lehar 4
Chairperson's Remarks
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
13:45 - 14:1530 mins
Cell Line Development and Engineering - Strauss 2 and 3
Stable cell lines for large scale lentiviral vector manufacture
- Sabine Johnson - Investigator, Cell Line Development, GSK
13:45 - 14:1530 mins
Cell Culture - Strauss 1
Accelerating upstream development timelines by combining hybrid modelling and advanced design space screening methods
- Mark Duerkop - Chief Executive Officer, Novasign
13:45 - 14:1530 mins
Recovery & Purification - Lehar 1 and 2
AI-ML Based Control Strategies for Control of Downstream Unit Operations in Continuous Manufacturing of mAbs
- Garima Thakur, Remote - Researcher, Indian Institute of Technology
13:45 - 14:1530 mins
Viral Safety - Lehar 3
Case Study: Manufacturer’s Experience of the ICH Q5(A)(R2) Guidelines
- Marie Murphy, Remote - Technical Services Manufacturing Network, Eli Lilly and Company, Ireland, EFPIA
13:45 - 14:1530 mins
Cell & Gene Therapy - Lehar 4
Controlling Manufacturing Processes in Pre-Commercial and Commercial Autologous Cell & Gene Therapy Products
- Amandine Breton - Associate Director of Cell Process MSAT, Orchard Therapeutics
14:15 - 14:4530 mins
Cell Line Development and Engineering - Strauss 2 and 3
Localization and structural characterization of random transgene integration of CHO manufacturing clones using next generation sequencing
- Benjamin Linder - Data Scientist, Boehringer Ingelheim
14:15 - 14:4530 mins
Cell Culture - Strauss 1
Advanced simulation of bioreactors
- Christian Witz - CEO, SimVantage
14:15 - 14:4530 mins
Recovery & Purification - Lehar 1 and 2
Design & Construction of a Truly Continuous and Automated Process Skid for the Production and Purification of a Monoclonal Antibody
- Bernhard Sissolak - Project Manager - End2End – Continuous Integrated Manufacturing, Bilfinger Industrietechnik Salzburg GmbH
14:15 - 14:4530 mins
Viral Safety - Lehar 3
Detergent-mediated virus inactivation in biotechnological matrices: More than just CMC
- Michael Karbiener, PhD - Head of Virological Method & Assay Development at Global Pathogen Safety, Takeda
14:15 - 14:4530 mins
Cell & Gene Therapy - Lehar 4
Platform Approaches for Process Understanding Across Different Biopharmaceutical Sectors: Varying Starting Raw Material in ATMP Processes
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:45 - 15:1530 mins
Cell Line Development and Engineering - Strauss 2 and 3
Improve your cell line development processes through rapid and low volume automated cell counting on the ICONTM instrument with STUDIUSTM data management software
- Camilla Domeneghetti - Laboratory Manager, Advanced Instruments
14:45 - 15:1530 mins
Cell Culture - Strauss 1
Please Move To Another Track
14:45 - 15:1530 mins
Recovery & Purification - Lehar 1 and 2
Contribution to the Global Virus Safety Against Emerging Viruses
- Sebastian Teitz - Scientific Coordinator, Asahi Kasei Bioprocess Europe
14:45 - 15:1530 mins
Viral Safety - Lehar 3
A Quality by Design Approach to Viral Clearance: Predicting LRV through the Use of non-Infectious MVM and RVLP Surrogates
- Alla Zilberman, Ph.D. - VP Technical Marketing, Cygnus Technologies, LLC
14:45 - 15:0015 mins
Cell & Gene Therapy - Lehar 4
Next-Generation Transfection Reagent for High Yield, Large Scale and Cost-Effective AAV Manufacturing
- Guillaume Freund - Scientific Support Manager, Polyplus-transfection
15:00 - 15:1515 mins
Cell & Gene Therapy - Lehar 4
HIP-Vax®: Solving the GMP Capacity Shortage for Viral Vector Production
- Angelique Lemckert - Technical Lead, Batavia Biosciences
15:15 - 15:5035 mins
General Session
Networking Refreshment Break
15:50 - 16:0010 mins
General Session
Chairperson's Remarks
- Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC
16:00 - 17:0060 mins
Plenary Session - Strauss 2 and 3
Keynote Address: Process Control Strategy, Residual Uncertainty, and the Myth of Fingerprints
- Jeffrey Baker, Remote - Senior Fellow, NIIMBL, Senior Strategy Advisor of CBI, MIT, former Deputy Director, Office of Biotechnology Products, CDER, US FDA
17:00 - 18:3090 mins
General Session
Cocktail Reception and Grand Opening of Exhibit & Poster Hall
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Choose Day